Dual modification of Alzheimer’s disease PHF-tau protein by lysine methylation and ubiquitylation: a mass spectrometry approach

Author： Thomas Stefani Funk Kristen Wan Yunhu Liao Zhongping Davies Peter Kuret Jeff Yang Austin

Publisher： Springer Publishing Company

ISSN： 0001-6322

Source： Acta Neuropathologica, Vol.123, Iss.1, 2012-01, pp. : 105-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phosphorylation of tau protein to sites found in Alzheimer's disease brain is catalyzed by Ca 2+ /calmodulin-dependent protein kinase II as demonstrated tandem mass spectrometry

By Yoshimura Y. Ichinose T. Yamauchi T.

Neuroscience Letters, Vol. 353, Iss. 3, 2003-12 ,pp. : 185-188

Elsevier

Access to resources Recommend Favorite

Tau Therapeutics for Alzheimer’s Disease : The Promise and the Challenges

By Gold Michael

Journal of Molecular Neuroscience, Vol. 19, Iss. 3, 2002-12 ,pp. : 329-334

Humana Press, Inc

Access to resources Recommend Favorite

Tau as a Drug Target in Alzheimer’s Disease

By Gozes Illana

Journal of Molecular Neuroscience, Vol. 19, Iss. 3, 2002-12 ,pp. : 337-338

Humana Press, Inc

Access to resources Recommend Favorite

β-Protein/A4 deposits are not associated with hyperphosphorylated tau in somatostatin neurons in the hypothalamus of Alzheimer’s disease patients

By Nes J. Konermann S. Nafe R. Swaab D.

Acta Neuropathologica, Vol. 111, Iss. 2, 2006-02 ,pp. : 126-138

Springer Publishing Company

Access to resources Recommend Favorite

Amyloid precursor protein and tau transgenic models of Alzheimer’s disease: insights from the past and directions for the future

By Sahara Naruhiko Lewis Jada

Future Neurology, Vol. 5, Iss. 3, 2010-05 ,pp. : 411-420

Future Medicine

Access to resources Recommend Favorite